Portfolio Holdings Detail for ISIN IE00BMBKBZ46
Stock Name / Fund iShares S&P 500 Health Care Sector UCITS ETF
Issuer Blackrock
Entity holding fund iShares V Public Limited Company
Entity Type
Entity LEI 549300QETNU1W5JY7Z94
ETF Ticker IUHE.AS(EUR) CXE
ETF Ticker IUHE(EUR) Euronext Amsterdam

Holdings detail for LH

Stock Name	Laboratory Corporation of America Holdings
Ticker	LH(USD) NYSE
TYPE	Common Stock
Country	USA
ISIN	US50540R4092
LEI	OZ7UA8IXAIFILY2VZH07

Show aggregate LH holdings

News associated with LH

Labcorp Announces Availability Of Lumipulse PTau-217/Beta Amyloid 42 Ratio For Alzheimer's Diagnosis: (RTTNews) - Labcorp Holdings Inc. (LH), Monday announced the availability of the Lumipulse pTau-217/Beta Amyloid 42 Ratio, a blood-based in-vitro diagnostic test to aid in the diagnosis of Alzheimer's disease. - 2025-08-18 08:35:08
Analysts Expect 10% Gains Ahead For The Holdings of SPUS: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-11 10:38:26
Truist Financial Issues Positive Forecast for Labcorp (NYSE:LH) Stock Price: Labcorp (NYSE:LH – Free Report) had its target price boosted by Truist Financial from $290.00 to $310.00 in a research report released on Friday morning,Benzinga reports. Truist Financial currently has a buy rating on the medical research company’s stock. Several other equities analysts also recently issued reports on LH. Morgan Stanley upped their price objective […] - 2025-07-28 04:00:48
Labcorp (NYSE:LH) Given New $305.00 Price Target at UBS Group: Labcorp (NYSE:LH – Free Report) had its price objective increased by UBS Group from $282.00 to $305.00 in a research note published on Friday,Benzinga reports. UBS Group currently has a buy rating on the medical research company’s stock. Several other brokerages have also recently weighed in on LH. Robert W. Baird boosted their price objective […] - 2025-07-28 04:00:47
Labcorp (NYSE:LH) Price Target Raised to $302.00: Labcorp (NYSE:LH – Free Report) had its price objective hoisted by Robert W. Baird from $290.00 to $302.00 in a research report sent to investors on Friday,Benzinga reports. The brokerage currently has an outperform rating on the medical research company’s stock. Several other equities research analysts have also weighed in on the stock. UBS Group […] - 2025-07-28 03:14:44
Labcorp (NYSE:LH) Raised to Buy at Wall Street Zen: Labcorp (NYSE:LH – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday. Other analysts also recently issued research reports about the stock. HSBC downgraded shares of Labcorp from a “buy” rating to a “hold” rating and set a […] - 2025-07-28 03:14:44
Labcorp (NYSE:LH) Price Target Raised to $306.00: Labcorp (NYSE:LH – Free Report) had its price target increased by Morgan Stanley from $283.00 to $306.00 in a research report report published on Friday morning,Benzinga reports. Morgan Stanley currently has an overweight rating on the medical research company’s stock. LH has been the subject of several other reports. Truist Financial raised their price objective […] - 2025-07-28 03:14:44
S&P 500 and Nasdaq 100 Post Record Highs on Tech Stock Strength: The S&P 500 Index ($SPX ) (SPY ) Thursday closed up +0.07%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.70%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.25%. September E-mini S&P futures (ESU25 ) rose +0.09%, and September E-mini Nasdaq futures (NQU25... - 2025-07-25 13:10:58
S&P 500 and Nasdaq 100 Post Record Highs on Tech Stock Strength: The S&P 500 Index ($SPX ) (SPY ) Thursday closed up +0.07%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.70%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.25%. September E-mini S&P futures (ESU25 ) rose +0.09%, and September E-mini Nasdaq futures (NQU25... - 2025-07-25 12:33:48
S&P 500 and Nasdaq 100 Post Record Highs on Tech Stock Strength: The S&P 500 Index ($SPX ) (SPY ) Thursday closed up +0.07%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.70%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.25%. September E-mini S&P futures (ESU25 ) rose +0.09%, and September E-mini Nasdaq futures (NQU25... - 2025-07-25 10:46:15
S&P 500 and Nasdaq 100 Post Record Highs on Tech Stock Strength: The S&P 500 Index ($SPX ) (SPY ) Thursday closed up +0.07%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.70%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.25%. September E-mini S&P futures (ESU25 ) rose +0.09%, and September E-mini Nasdaq futures (NQU25... - 2025-07-25 09:43:18
S&P 500 and Nasdaq 100 Post Record Highs on Tech Stock Strength: The S&P 500 Index ($SPX ) (SPY ) Thursday closed up +0.07%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.70%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.25%. September E-mini S&P futures (ESU25 ) rose +0.09%, and September E-mini Nasdaq futures (NQU25... - 2025-07-25 08:39:33
S&P 500 and Nasdaq 100 Post Record Highs on Tech Stock Strength: The S&P 500 Index ($SPX ) (SPY ) Thursday closed up +0.07%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.70%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.25%. September E-mini S&P futures (ESU25 ) rose +0.09%, and September E-mini Nasdaq futures (NQU25... - 2025-07-25 06:56:05
S&P 500 and Nasdaq 100 Post Record Highs on Tech Stock Strength: The S&P 500 Index ($SPX ) (SPY ) Thursday closed up +0.07%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.70%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.25%. September E-mini S&P futures (ESU25 ) rose +0.09%, and September E-mini Nasdaq futures (NQU25... - 2025-07-25 05:49:13
S&P 500 and Nasdaq 100 Post Record Highs on Tech Stock Strength: The S&P 500 Index ($SPX ) (SPY ) Thursday closed up +0.07%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.70%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.25%. September E-mini S&P futures (ESU25 ) rose +0.09%, and September E-mini Nasdaq futures (NQU25... - 2025-07-25 01:46:32
Stocks Gain on Tech Earnings and US Labor Market Strength: The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.21%. September E-mini S&P futures (ESU25 ) are up +0.23%, and September E-mini Nasdaq futures... - 2025-07-24 20:56:17
Stocks Supported by Strong Earnings from Alphabet: The S&P 500 Index ($SPX ) (SPY ) today is up +0.08%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.67%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.18%. September E-mini S&P futures (ESU25 ) are up +0.08%, and September E-mini Nasdaq futures... - 2025-07-24 20:56:16
Stocks Gain on Tech Earnings and US Labor Market Strength: The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.21%. September E-mini S&P futures (ESU25 ) are up +0.23%, and September E-mini Nasdaq futures... - 2025-07-24 14:14:57
Stocks Supported by Strong Earnings from Alphabet: The S&P 500 Index ($SPX ) (SPY ) today is up +0.08%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.67%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.18%. September E-mini S&P futures (ESU25 ) are up +0.08%, and September E-mini Nasdaq futures... - 2025-07-24 13:27:48
Labcorp Boosts FY25 Outlook - Update: (RTTNews) - While reporting financial results for the second quarter on Thursday, life sciences company Labcorp (LH) raised its adjusted earnings and revenue guidance for the full-year 2025 to reflect its second quarter performance and full year outlook. - 2025-07-24 08:41:35
Larson Financial Group LLC Increases Stock Position in Labcorp Holdings Inc. (NYSE:LH): Larson Financial Group LLC boosted its stake in Labcorp Holdings Inc. (NYSE:LH – Free Report) by 140.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 125 shares of the medical research company’s stock after purchasing an additional 73 shares during […] - 2025-07-23 05:53:06
Signaturefd LLC Increases Stock Holdings in Labcorp Holdings Inc. (NYSE:LH): Signaturefd LLC boosted its position in Labcorp Holdings Inc. (NYSE:LH – Free Report) by 9.7% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 645 shares of the medical research company’s stock after purchasing an additional 57 shares during the period. Signaturefd LLC’s holdings in Labcorp […] - 2025-07-21 05:43:02
UBS Group Cuts Labcorp (NYSE:LH) Price Target to $282.00: Labcorp (NYSE:LH – Free Report) had its price target decreased by UBS Group from $284.00 to $282.00 in a report released on Friday,Benzinga reports. UBS Group currently has a buy rating on the medical research company’s stock. Several other analysts have also recently commented on LH. Hsbc Global Res cut shares of Labcorp from a […] - 2025-07-21 04:54:54
Labcorp Holdings Inc. (NYSE:LH) Receives $276.08 Average PT from Brokerages: Shares of Labcorp Holdings Inc. (NYSE:LH – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the fourteen brokerages that are currently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, three have issued a hold rating, nine have issued a buy rating and […] - 2025-07-11 04:01:04
Labcorp Holdings Inc. (NYSE:LH) Shares Acquired by D.A. Davidson & CO.: D.A. Davidson & CO. lifted its holdings in shares of Labcorp Holdings Inc. (NYSE:LH – Free Report) by 1.8% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 11,851 shares of the medical research company’s stock after buying an additional 204 shares during the quarter. D.A. Davidson & CO.’s holdings in Labcorp were […] - 2025-07-07 07:13:02
DAVENPORT & Co LLC Sells 269 Shares of Labcorp Holdings Inc. (NYSE:LH): DAVENPORT & Co LLC trimmed its position in Labcorp Holdings Inc. (NYSE:LH – Free Report) by 6.7% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 3,720 shares of the medical research company’s stock after selling 269 shares during the quarter. DAVENPORT & Co LLC’s holdings in Labcorp were worth $866,000 as of its […] - 2025-07-07 05:54:49
Vontobel Holding Ltd. Trims Stock Position in Labcorp Holdings Inc. (NYSE:LH): Vontobel Holding Ltd. lessened its stake in shares of Labcorp Holdings Inc. (NYSE:LH – Free Report) by 43.5% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,832 shares of the medical research company’s stock after selling 2,177 shares during the quarter. Vontobel Holding […] - 2025-07-07 05:03:35
Amalgamated Bank Grows Position in Labcorp Holdings Inc. (NYSE:LH): Amalgamated Bank increased its position in shares of Labcorp Holdings Inc. (NYSE:LH – Free Report) by 1.5% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 16,303 shares of the medical research company’s stock after buying an additional 248 shares during the period. Amalgamated Bank’s holdings […] - 2025-07-04 05:24:51
Labcorp Holdings Inc. (NYSE:LH) Stock Holdings Lifted by Cambridge Investment Research Advisors Inc.: Cambridge Investment Research Advisors Inc. increased its position in shares of Labcorp Holdings Inc. (NYSE:LH – Free Report) by 0.9% during the first quarter, Holdings Channel reports. The fund owned 10,075 shares of the medical research company’s stock after acquiring an additional 92 shares during the quarter. Cambridge Investment Research Advisors Inc.’s holdings in Labcorp […] - 2025-07-02 04:38:52
Chevy Chase Trust Holdings LLC Sells 308 Shares of Labcorp Holdings Inc. (NYSE:LH): Chevy Chase Trust Holdings LLC lowered its position in Labcorp Holdings Inc. (NYSE:LH – Free Report) by 0.6% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 47,565 shares of the medical research company’s stock after selling 308 shares during the […] - 2025-06-27 05:12:50

iShares S&P 500 Health Care Sector UCITS ETF LH holdings

Date	Number of LH Shares Held	Base Market Value of LH Shares	Local Market Value of LH Shares	Change in LH Shares Held	Change in LH Base Value	Current Price per LH Share Held	Previous Price per LH Share Held
2025-09-26 (Friday)	39,489	USD 11,081,008	USD 11,081,008
2025-09-25 (Thursday)	39,489	USD 10,904,492	USD 10,904,492	0	USD -126,760	USD 276.14	USD 279.35
2025-09-24 (Wednesday)	39,489	USD 11,031,252	USD 11,031,252
2025-09-18 (Thursday)	39,489	USD 10,944,376	USD 10,944,376	46	USD 55,347	USD 277.15	USD 276.07
2025-09-17 (Wednesday)	39,443	USD 10,889,029	USD 10,889,029	0	USD 78,097	USD 276.07	USD 274.09
2025-09-16 (Tuesday)	39,443	USD 10,810,932	USD 10,810,932	0	USD -51,670	USD 274.09	USD 275.4
2025-09-15 (Monday)	39,443	USD 10,862,602	USD 10,862,602
2025-09-12 (Friday)	39,443	USD 10,963,182	USD 10,963,182
2025-09-11 (Thursday)	39,321	USD 10,998,870	USD 10,998,870	46	USD 279,151	USD 279.72	USD 272.94

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LH by Blackrock for IE00BMBKBZ46

Show aggregate share trades of LH

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-09-18 BUY 46 277.150* 245.56
2025-09-11 BUY 46 279.720* 245.04
2025-09-10 BUY 46 272.940* 244.88
2025-08-20 BUY 92 278.100* 244.31
2025-08-19 BUY 46 275.770* 244.13
2025-08-18 BUY 230 270.490* 243.98
2025-08-15 BUY 685 270.380* 243.82
2025-08-14 BUY 276 271.250* 243.66
2025-08-13 BUY 184 272.540* 243.49
2025-07-30 BUY 46 263.910* 243.21
2025-07-17 SELL -46 247.240* 242.54 Profit of 11,157 on sale
2025-07-15 SELL -184 245.650* 242.50 Profit of 44,620 on sale
2025-07-14 SELL -460 249.800* 242.46 Profit of 111,529 on sale
2025-07-09 SELL -46 259.070* 242.22 Profit of 11,142 on sale
2025-07-07 SELL -92 257.870* 242.02 Profit of 22,266 on sale
2025-07-02 BUY 46 260.000* 241.62
2025-06-24 SELL -782 262.530* 240.96 Profit of 188,431 on sale
2025-06-23 BUY 46 261.040* 240.82
2025-06-20 BUY 719 261.880* 240.67
2025-06-18 SELL -45 261.390* 240.36 Profit of 10,816 on sale
2025-06-17 BUY 540 259.450* 240.22
2025-06-13 SELL -90 261.120* 239.89 Profit of 21,590 on sale
2025-06-11 SELL -45 259.950* 239.57 Profit of 10,781 on sale
2025-06-10 SELL -90 259.370* 239.42 Profit of 21,548 on sale
2025-06-09 SELL -135 255.730* 239.30 Profit of 32,305 on sale
2025-05-21 SELL -45 241.340* 238.38 Profit of 10,727 on sale
2025-05-20 SELL -90 250.800* 238.28 Profit of 21,445 on sale
2025-05-15 SELL -135 246.270* 238.00 Profit of 32,131 on sale
2025-05-14 SELL -135 242.370* 237.97 Profit of 32,125 on sale
2025-05-13 BUY 45 250.010* 237.86
2025-05-09 SELL -45 245.730* 237.66 Profit of 10,695 on sale
2025-05-08 BUY 90 248.760* 237.56
2025-05-01 BUY 90 241.280* 237.19
2025-04-24 SELL -45 228.580* 237.38 Profit of 10,682 on sale
2025-04-23 BUY 135 224.140* 237.52
2025-04-15 SELL -45 226.020* 238.74 Profit of 10,743 on sale
2025-04-10 SELL -90 218.610* 239.29 Profit of 21,536 on sale
2025-04-08 SELL -45 217.680* 239.64 Profit of 10,784 on sale
2025-04-07 SELL -45 223.500* 239.83 Profit of 10,793 on sale
2025-04-04 SELL -90 225.000* 240.01 Profit of 21,601 on sale
2025-04-02 BUY 45 236.370* 240.06
2025-04-01 BUY 405 232.650* 240.15
2025-03-31 SELL -270 232.740* 240.24 Profit of 64,864 on sale
2025-03-28 BUY 45 230.020* 240.36
2025-03-26 SELL -27 233.340* 240.57 Profit of 6,495 on sale
2025-03-21 BUY 315 234.210* 240.79
2025-03-20 BUY 180 235.780* 240.86
2025-03-17 SELL -45 240.430* 240.89 Profit of 10,840 on sale
2025-03-12 SELL -259 236.830* 241.05 Profit of 62,432 on sale
2025-03-07 BUY 45 253.030* 240.85
2025-02-28 SELL -135 251.040* 239.98 Profit of 32,397 on sale
2025-02-25 BUY 450 252.870* 239.42
2025-02-20 BUY 315 249.170* 238.83
2025-02-19 BUY 135 247.820* 238.66
2025-02-18 BUY 90 246.290* 238.52
2025-02-13 BUY 225 244.870* 238.07
2025-02-04 BUY 180 246.670* 236.78
2025-01-31 BUY 45 249.800* 236.20
2025-01-29 BUY 45 246.220* 235.54
2025-01-27 BUY 90 249.670* 234.81
2025-01-24 BUY 45 246.000* 234.50
2025-01-02 SELL -1,620 228.190* 234.40 Profit of 379,726 on sale
2024-12-10 SELL -45 234.540* 234.39 Profit of 10,548 on sale
2024-12-09 SELL -1,170 236.000* 234.34 Profit of 274,183 on sale
2024-12-03 SELL -540 240.570* 234.06 Profit of 126,391 on sale
2024-12-02 SELL -225 240.630* 233.81 Profit of 52,608 on sale
2024-11-29 SELL -45 241.160* 233.53 Profit of 10,509 on sale
2024-11-22 SELL -450 239.670* 231.80 Profit of 104,310 on sale
2024-11-21 SELL -225 240.170* 231.38 Profit of 52,061 on sale
2024-11-20 BUY 360 237.850* 231.04
2024-11-18 SELL -540 238.640* 230.29 Profit of 124,356 on sale
2024-11-11 BUY 405 243.920* 228.45
2024-11-08 SELL -1,440 242.390* 227.45 Profit of 327,533 on sale
2024-11-07 SELL -90 239.050* 226.56 Profit of 20,391 on sale
2024-11-01 SELL -90 227.100* 225.28 Profit of 20,275 on sale
2024-10-31 SELL -180 228.270* 224.91 Profit of 40,484 on sale
2024-10-30 BUY 45 230.560* 224.10
2024-10-29 BUY 270 228.090* 223.44
2024-10-28 SELL -135 227.380* 222.65 Profit of 30,057 on sale
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-09-18	BUY	46	277.150*	245.56
2025-09-11	BUY	46	279.720*	245.04
2025-09-10	BUY	46	272.940*	244.88
2025-08-20	BUY	92	278.100*	244.31
2025-08-19	BUY	46	275.770*	244.13
2025-08-18	BUY	230	270.490*	243.98
2025-08-15	BUY	685	270.380*	243.82
2025-08-14	BUY	276	271.250*	243.66
2025-08-13	BUY	184	272.540*	243.49
2025-07-30	BUY	46	263.910*	243.21
2025-07-17	SELL	-46	247.240*	242.54 Profit of 11,157 on sale
2025-07-15	SELL	-184	245.650*	242.50 Profit of 44,620 on sale
2025-07-14	SELL	-460	249.800*	242.46 Profit of 111,529 on sale
2025-07-09	SELL	-46	259.070*	242.22 Profit of 11,142 on sale
2025-07-07	SELL	-92	257.870*	242.02 Profit of 22,266 on sale
2025-07-02	BUY	46	260.000*	241.62
2025-06-24	SELL	-782	262.530*	240.96 Profit of 188,431 on sale
2025-06-23	BUY	46	261.040*	240.82
2025-06-20	BUY	719	261.880*	240.67
2025-06-18	SELL	-45	261.390*	240.36 Profit of 10,816 on sale
2025-06-17	BUY	540	259.450*	240.22
2025-06-13	SELL	-90	261.120*	239.89 Profit of 21,590 on sale
2025-06-11	SELL	-45	259.950*	239.57 Profit of 10,781 on sale
2025-06-10	SELL	-90	259.370*	239.42 Profit of 21,548 on sale
2025-06-09	SELL	-135	255.730*	239.30 Profit of 32,305 on sale
2025-05-21	SELL	-45	241.340*	238.38 Profit of 10,727 on sale
2025-05-20	SELL	-90	250.800*	238.28 Profit of 21,445 on sale
2025-05-15	SELL	-135	246.270*	238.00 Profit of 32,131 on sale
2025-05-14	SELL	-135	242.370*	237.97 Profit of 32,125 on sale
2025-05-13	BUY	45	250.010*	237.86
2025-05-09	SELL	-45	245.730*	237.66 Profit of 10,695 on sale
2025-05-08	BUY	90	248.760*	237.56
2025-05-01	BUY	90	241.280*	237.19
2025-04-24	SELL	-45	228.580*	237.38 Profit of 10,682 on sale
2025-04-23	BUY	135	224.140*	237.52
2025-04-15	SELL	-45	226.020*	238.74 Profit of 10,743 on sale
2025-04-10	SELL	-90	218.610*	239.29 Profit of 21,536 on sale
2025-04-08	SELL	-45	217.680*	239.64 Profit of 10,784 on sale
2025-04-07	SELL	-45	223.500*	239.83 Profit of 10,793 on sale
2025-04-04	SELL	-90	225.000*	240.01 Profit of 21,601 on sale
2025-04-02	BUY	45	236.370*	240.06
2025-04-01	BUY	405	232.650*	240.15
2025-03-31	SELL	-270	232.740*	240.24 Profit of 64,864 on sale
2025-03-28	BUY	45	230.020*	240.36
2025-03-26	SELL	-27	233.340*	240.57 Profit of 6,495 on sale
2025-03-21	BUY	315	234.210*	240.79
2025-03-20	BUY	180	235.780*	240.86
2025-03-17	SELL	-45	240.430*	240.89 Profit of 10,840 on sale
2025-03-12	SELL	-259	236.830*	241.05 Profit of 62,432 on sale
2025-03-07	BUY	45	253.030*	240.85
2025-02-28	SELL	-135	251.040*	239.98 Profit of 32,397 on sale
2025-02-25	BUY	450	252.870*	239.42
2025-02-20	BUY	315	249.170*	238.83
2025-02-19	BUY	135	247.820*	238.66
2025-02-18	BUY	90	246.290*	238.52
2025-02-13	BUY	225	244.870*	238.07
2025-02-04	BUY	180	246.670*	236.78
2025-01-31	BUY	45	249.800*	236.20
2025-01-29	BUY	45	246.220*	235.54
2025-01-27	BUY	90	249.670*	234.81
2025-01-24	BUY	45	246.000*	234.50
2025-01-02	SELL	-1,620	228.190*	234.40 Profit of 379,726 on sale
2024-12-10	SELL	-45	234.540*	234.39 Profit of 10,548 on sale
2024-12-09	SELL	-1,170	236.000*	234.34 Profit of 274,183 on sale
2024-12-03	SELL	-540	240.570*	234.06 Profit of 126,391 on sale
2024-12-02	SELL	-225	240.630*	233.81 Profit of 52,608 on sale
2024-11-29	SELL	-45	241.160*	233.53 Profit of 10,509 on sale
2024-11-22	SELL	-450	239.670*	231.80 Profit of 104,310 on sale
2024-11-21	SELL	-225	240.170*	231.38 Profit of 52,061 on sale
2024-11-20	BUY	360	237.850*	231.04
2024-11-18	SELL	-540	238.640*	230.29 Profit of 124,356 on sale
2024-11-11	BUY	405	243.920*	228.45
2024-11-08	SELL	-1,440	242.390*	227.45 Profit of 327,533 on sale
2024-11-07	SELL	-90	239.050*	226.56 Profit of 20,391 on sale
2024-11-01	SELL	-90	227.100*	225.28 Profit of 20,275 on sale
2024-10-31	SELL	-180	228.270*	224.91 Profit of 40,484 on sale
2024-10-30	BUY	45	230.560*	224.10
2024-10-29	BUY	270	228.090*	223.44
2024-10-28	SELL	-135	227.380*	222.65 Profit of 30,057 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LH

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	81,112	0	131,889	61.5%
2025-09-18	80,924	0	126,699	63.9%
2025-09-17	111,759	0	149,359	74.8%
2025-09-16	75,403	0	116,462	64.7%
2025-09-15	105,770	49	166,532	63.5%
2025-09-12	86,225	54	118,245	72.9%
2025-09-11	81,092	340	147,405	55.0%
2025-09-10	97,987	81	199,075	49.2%
2025-09-09	92,468	0	158,543	58.3%
2025-09-08	122,905	0	327,772	37.5%
2025-09-05	47,303	0	88,274	53.6%
2025-09-04	35,073	0	92,117	38.1%
2025-09-03	60,656	0	133,681	45.4%
2025-09-02	57,280	45	177,008	32.4%
2025-08-29	53,024	896	123,720	42.9%
2025-08-28	44,282	0	95,701	46.3%
2025-08-27	74,905	131	111,428	67.2%
2025-08-26	102,360	0	161,914	63.2%
2025-08-25	64,809	0	116,537	55.6%
2025-08-22	106,216	0	192,173	55.3%
2025-08-21	75,139	0	142,239	52.8%
2025-08-20	124,436	0	264,992	47.0%
2025-08-19	183,183	180	353,720	51.8%
2025-08-18	85,719	62	183,744	46.7%
2025-08-15	54,344	0	110,766	49.1%
2025-08-14	63,834	0	115,582	55.2%
2025-08-13	103,141	0	238,749	43.2%
2025-08-12	87,712	0	157,127	55.8%
2025-08-11	112,877	0	228,413	49.4%
2025-08-08	108,108	0	205,966	52.5%
2025-08-07	67,743	0	201,212	33.7%
2025-08-06	79,810	0	170,535	46.8%
2025-08-05	71,643	343	207,366	34.5%
2025-08-04	106,116	15	206,824	51.3%
2025-08-01	123,618	15	247,524	49.9%
2025-07-31	109,193	0	188,922	57.8%
2025-07-30	108,930	0	190,861	57.1%
2025-07-29	96,546	0	205,606	47.0%
2025-07-28	114,843	18	233,217	49.2%
2025-07-25	195,221	420	465,855	41.9%
2025-07-24	283,328	110	827,061	34.3%
2025-07-23	163,534	100	381,429	42.9%
2025-07-22	182,829	295	340,919	53.6%
2025-07-21	113,536	10	245,928	46.2%
2025-07-18	70,028	0	155,973	44.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares S&P 500 Health Care Sector UCITS ETF
Issuer	Blackrock
Entity holding fund	iShares V Public Limited Company
Entity Type
Entity LEI	549300QETNU1W5JY7Z94
ETF Ticker	IUHE.AS(EUR) CXE
ETF Ticker	IUHE(EUR) Euronext Amsterdam